Pharmacyclics-heading Uphill On Cancer Drug Push

Boston, MA 02/19/2013 (wallstreetpr)- Pharmacyclics, Inc (NASDAQ:PCYC) has been working in collaboration with Johnson & Johnson (NYSE:JNJ) on Ibrutinib, the leukemia and mantle cell lymphoma treatment drug. Late 2014 would see the launch of the very first drug that the company would be selling if it gets market approved by FDA. In 2012, FDA had […]